EverlyWell was founded in 2014 by Julia Cheek. In 2021, parent company Everly Health hired two experienced financial executives, bringing on Chris Bishko as CFO and Kristina Omari as VP of Finance. Omari helped guide Lyft through an IPO in 2019. When asked about an IPO, Cheek told Bizjournals that she was "excited about the future of Everly Health and the opportunity to grow to serve even more Americans — certainly, these appointments positions us to do so." These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.
EverlyWell describes itself as "a consumer health testing company that connects people with accessible, innovative, and insightful at-home lab tests." In 2021 the company acquired Everly Health Solutions and Home Access Health. EverlyWell has received over $330 million in funding from investors including HealthQuest Capital, Morningside Ventures, Lux Capital, The Chernin Group, and Next Coast Ventures. A recent round of funding brought in $175 million and resulted in a $1.3 billion post-money valuation — a significant increase from the previous year.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
12/27/2021 | Series F | $154.68MM | $xx.xx | $3.5B | Prysm Capital, Touchdown Ventures | |
Price per Share
$xx.xx
Shares Outstanding
2,400,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Prysm Capital, Touchdown Ventures
|
||||||
03/23/2021 | Series E | $192.92MM | $xx.xx | $2.69B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
3,768,393
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
12/03/2020 | Series D | $258.1MM | $xx.xx | $1.32B | Blackrock, Foresite Capital, Greenspring Associates, Highland Capital Partners, Morningside Ventures, Portfolio, The Chernin Group | |
Price per Share
$xx.xx
Shares Outstanding
9,879,426
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Blackrock, Foresite Capital, Greenspring Associates, Highland Capital Partners, Morningside Ventures, Portfolio, The Chernin Group
|
||||||
02/21/2020 | Series C | $25MM | $xx.xx | $226.76MM | Goodwater Capital, Next Coast Ventures, Nextgen Venture Partners | |
Price per Share
$xx.xx
Shares Outstanding
4,032,450
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Goodwater Capital, Next Coast Ventures, Nextgen Venture Partners
|
||||||
04/16/2019 | Series B | $29.63MM | $xx.xx | $154.74MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
6,884,140
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
12/28/2017 | Series A-1 | $1.46MM | $xx.xx | $37.76MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,523,561
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
12/28/2017 | Series A | $9.16MM | $xx.xx | $37.76MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
7,083,005
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
04/19/2016 | Series Seed | $3.14MM | $xx.xx | $8.98MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
4,174,804
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|